The aim was to evaluate and compare the presence of myofibroblasts in oral squamous cell carcinoma (OSCC), verrucous carcinoma (VC), high-risk epithelial dysplasia (HRED), low-risk epithelial dysplasia (LRED), and normal oral mucosa (NOM). The study consisted of 37 OSCC, 15 VC, 15 HRED, 15 LRED and 15 NOM. a-smooth muscle actin (a-SMA) antibody was used to identify myofibroblasts. The a-SMA expression was not observed in NOM and LRED. The a-SMA was expressed in 97.29% of OSCC, 86.66% of VC, 46.66 % of HRED. The a-SMA expression was significantly higher in OSCC than VC (p = 0.023) and HRED (p \ 0.000). The a-SMA expression was significantly higher in VC than HRED (p = 0.043). Myofibroblastic expression, as highlighted by a-SMA, is undetectable in NOM and LRED but increases as the disease progresses from potentially malignant disorders, as HRED to VC to invasive OSCC. Thus, proliferation of myofibroblasts may be used as a stromal marker of oral premalignancy and malignancy.